Literature DB >> 3603100

Eye Injury Registry of Alabama (preliminary report): demographics and prognosis of severe eye injury.

R E Morris, C D Witherspoon, H A Helms, R M Feist, J B Byrne.   

Abstract

Each year an estimated 1.3 million Americans suffer eye injuries. There is little information in the literature regarding the prevalence, demographic characteristics, and prognosis of these patients. The Eye Injury Registry of Alabama (EIRA) serves as the first and only statewide system of its kind for the collection of information on serious eye injuries. We have analyzed 736 cases of serious eye injury (injury involving permanent structural or functional change) accumulated by the EIRA between August 1982 and May 1986. Prognosis was found to be related to early diagnosis and initial vision. Individuals with follow-up vision of 20/40 or better were found in all early diagnostic groups, and 13% of patients with no light perception on initial examination had some improvement on follow-up. The worst visual prognosis was among those patients suffering blunt eyeball rupture, of whom 40% had no light perception and 25% regained vision of 20/100 or better.

Entities:  

Mesh:

Year:  1987        PMID: 3603100     DOI: 10.1097/00007611-198707000-00004

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  3 in total

1.  The burden of serious ocular injury.

Authors:  R J Cooling
Journal:  Br J Ophthalmol       Date:  1996-07       Impact factor: 4.638

2.  Characteristics and causes of penetrating eye injuries reported to the National Eye Trauma System Registry, 1985-91.

Authors:  L M Parver; A L Dannenberg; B Blacklow; C J Fowler; R J Brechner; J M Tielsch
Journal:  Public Health Rep       Date:  1993 Sep-Oct       Impact factor: 2.792

3.  Hospitalized eye injury in a large industrial city of South-Eastern Asia.

Authors:  Cheng-Hsien Chang; Chang-Ling Chen; Chi-Kung Ho; Yu-Hong Lai; Ru-Chuan Hu; Ya-Lin Yen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-01-08       Impact factor: 3.117

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.